Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 261280 of 20,252 grants

Active TRAINING, INDIVIDUAL
Defining Novel Redox Stress Mechanisms to Inhibit KRAS-driven Pancreatic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2027

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths with a 5-year survival rate of 12%. Over 90% of PDAC is driven by oncogenic KRAS, howeve...

$489.7K
USD
Active TRAINING, INDIVIDUAL
Understanding Kras Mutation Heterogeneity in PDAC
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2027

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent neoplastic disease of the pancreas, and it is expected to become the second leading cause of cancer re...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Engineering the Premetastatic Niche
NATIONAL CANCER INSTITUTE Purdue University United States 2024 – 2029

Project Summary The majority of breast cancer related deaths occur as a result of metastasis. Once the cancer cells metastasize, the 5-year relative survival rate for breast cancer...

$5.21M
USD
Active NON-SBIR/STTR RPGS
Evaluation of combination CLK/DYRK (Cirtuvivint) inhibition with PARP inhibition (Olaparib) in BRCA/HRD platinum resistant ovarian cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Approximately 50% of patients with ovarian cancer harbor deficiencies in DNA damage repair with either a germline/somatic mutation in BRCA1/2 or homologous...

$4M
USD
Active NON-SBIR/STTR RPGS
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2029

PROJECT SUMMARY Current immunotherapies, such as anti-PD-1 immunotherapy, have low objective responses in patients, necessitating the development of novel therapies that boost immu...

$5.3M
USD
Active OTHER RESEARCH-RELATED
Investigating the mechanism of K17-mediated immunosuppression in papillomavirus-induced cancers
NATIONAL CANCER INSTITUTE Henry Ford Health + Michigan State Unive... United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT My long-term career goal is to become an independent scientist in an academic research institution. My research interest focuses on investigating novel mol...

$1.94M
USD
Active NON-SBIR/STTR RPGS
Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

PROJECT ABSTRACT Cancer-related fatigue (CRF) is one of the most common and functionally limiting symptoms reported by cancer survivors. While no standard of care exists for CRF ma...

$5.95M
USD
Active NON-SBIR/STTR RPGS
Harnessing digital health and equity informed multi-level implementation strategies to promote uptake of depression treatment in cancer settings: iCan DepCare
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

Cancer patients with elevated depressive symptoms have higher rates of cancer mortality, recurrence, diminished quality of life (QoL), healthcare expenditure, and chemotherapy nona...

$6.96M
USD
Active NON-SBIR/STTR RPGS
Assessing the efficacy of a ROR1:PD-L1:CD2 multispecific T cell engager in ROR1-positive and -negative neuroblastoma models
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Few children with recurrent neuroblastoma survive. New therapies, particularly immunotherapies, are badly needed. Some promising results have recently been...

$5.03M
USD
Active NON-SBIR/STTR RPGS
Adapting and testing a smoking cessation intervention for transgender and gender-diverse individuals
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2026

Despite the substantial decrease in the prevalence of smoking over the past 50-years, there are persistent and significant disparities in tobacco use among transgender and gender d...

$4.4M
USD
Active OTHER RESEARCH-RELATED
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Adolescent and young adult cancer survivors (AYACSs) face multiple disparities, including impaired psychosocial health, isolation, limited access to psycho...

$1.61M
USD
Active OTHER RESEARCH-RELATED
Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

PROJECT SUMMARY Of the 150,000 individuals diagnosed with colorectal cancer (CRC) each year, 15% will carry a hereditary pathogenic germline variant (PGV) including some associated...

$1.92M
USD
Active OTHER RESEARCH-RELATED
Preventing Cervical Cancer through HPV Self-collection and Patient Navigation among Women Living with Chronic Conditions and Social Vulnerability
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Despite advances across the cervical cancer care continuum – screening, treatment, and survivorship care, women with social vulnerability (i.e. poverty, ru...

$1.72M
USD
Active OTHER RESEARCH-RELATED
Using Single-cell and Spatial Multi-omics to Improve Adoptive Cell Therapy against Pancreatic Cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2026

Project Summary/Abstract Adoptive T cell therapy (ACT) has been effective against certain blood cancers but has had limited success against solid tumors, such as pancreatic cancers...

$1.69M
USD
Active NON-SBIR/STTR RPGS
Development of a pre-clinical syngeneic pig glioma model for research and translational studies
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2024 – 2026

Glioblastoma (GBM) is uniformly fatal with an incidence rate of 2.99-3.23 per 100,000 people. Despite recent therapeutic advances, our understanding of tumor biology in GBM remains...

$4.15M
USD
Active NON-SBIR/STTR RPGS
Dietary lipids as drivers and therapeutic targets in obesity-accelerated breast cancer
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2026

Summary Diet-induced obesity affects about 40 percent of US women and increases the incidence, morbidity, and mortality of postmenopausal breast cancer (BC). Obesity also increases...

$1.8M
USD
Active NON-SBIR/STTR RPGS
Vaping Cessation among youth: Evaluating the feasibility and efficacy of a virtual in-person CBT and an app-based CBT4CBT
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

PROJECT ABSTRACT E-cigarettes are the most popular nicotine-delivery devices used by US adolescents. Many adolescents do not like being addicted to e-cigarettes and want to quit. H...

$10.03M
USD
Active NON-SBIR/STTR RPGS
Activation of SLFN12 RNase Activity by Dimerization
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2024 – 2026

Velcrin compounds kill cancer cells expressing elevated levels of PDE3A and SLFN12 by inducing complex formation between these two proteins. Velcrin-induced PDE3A-SLFN12 complexes...

$1.54M
USD
Active NON-SBIR/STTR RPGS
Director Genomics Shared Resource
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT The current application seeks salary support for Prashant K. Singh, PhD who serves as the Director of the Genomics Shared Resource (GSR) at Roswell Park...

$2.36M
USD
Active NON-SBIR/STTR RPGS
Artificial Intelligence for effective communication to promote vaping cessation on social media
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2029

PROJECT SUMMARY The National Youth Tobacco Survey showed the prevalence of e-cigarette use among high school students has skyrocketed from 12% in 2017 to 28% in 2019 and remains hi...

$5.65M
USD